Pamoic acid[1]
Structural formula of pamoic acid
Names
Preferred IUPAC name
4,4′-Methylenebis(3-hydroxynaphthalene-2-carboxylic acid)
Other names
4,4′-Methylenebis(3-hydroxy-2-naphthoic acid)
Embonic acid
Identifiers
3D model (JSmol)
901319
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard 100.004.545
EC Number
  • 204-998-0
MeSH Pamoic+acid
RTECS number
  • QL2180000
UNII
  • InChI=1S/C23H16O6/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-10,24-25H,11H2,(H,26,27)(H,28,29) checkY
    Key: WLJNZVDCPSBLRP-UHFFFAOYSA-N checkY
  • OC(=O)C1=CC2=CC=CC=C2C(CC2=C(O)C(=CC3=CC=CC=C23)C(O)=O)=C1O
  • C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O
Properties
C23H16O6
Molar mass 388.375 g·mol−1
Melting point ≥300 °C
log P 6.169
Acidity (pKa) 2.675
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
 Causes skin irritation

Causes serious eye irritation
May cause respiratory irritation

Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Pamoic acid, also called embonic acid, is a 2-Naphthoic acid derivative. Salts and esters of pamoic acid are known as pamoates or embonates. It can be prepared by the reaction of 3-hydroxy-2-naphthoic acid with formaldehyde.

In pharmacology, the salt form of pamoic acid (pamoate ion) can be used as a counterion of a drug compound to affect the dissolution rate of the drug.[2] The presence of multiple oxygen atoms enables significant hydrogen bonding to occur. Hydrogen bonds facilitate the dissolution of compounds in water. Pharmaceutical drugs formulated this way include cycloguanil pamoate, hydroxyzine pamoate, imipramine pamoate, olanzapine pamoate hydrate, oxantel pamoate, pyrantel pamoate, and pyrvinium pamoate.

Pamoic acid has agonist activity for the orphan G protein-coupled receptor GPR35 by which it activates ERK and beta-arrestin2, and causes antinociceptive activity.[3][4]

References

  1. ↑ Merck Index, 12th Edition, 7136.
  2. ↑ Saesmaa, T; Tötterman, AM (1990). "Dissolution studies on ampicillin embonate and amoxycillin embonate". Journal of Pharmaceutical and Biomedical Analysis. 8 (1): 61–5. doi:10.1016/0731-7085(90)80007-c. PMID 2102266.
  3. ↑ Zhao, P.; Sharir, H.; Kapur, A.; Cowan, A.; Geller, E. B.; Adler, M. W.; Seltzman, H. H.; Reggio, P. H.; et al. (2010). "Targeting of the Orphan Receptor GPR35 by Pamoic Acid: A Potent Activator of Extracellular Signal-Regulated Kinase and -Arrestin2 with Antinociceptive Activity". Molecular Pharmacology. 78 (4): 560–8. doi:10.1124/mol.110.066746. PMC 2981393. PMID 20826425.
  4. ↑ Neubig, Richard R (2010). "Mind your salts: when the inactive constituent isn't". Molecular Pharmacology. 78 (4): 558–9. doi:10.1124/mol.110.067645. PMID 20651116. S2CID 1859819.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.